$PFE Recent News The inscrutable gold timers 10:
Post# of 145149
Posted On: 01/30/2014 1:32:06 PM
$PFE Recent News
The inscrutable gold timers 10:26 a.m. Today - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Stocks rebound, helping Dow quit loss streak; Yahoo drops after hours (Stock market live blog recap) 4:31 p.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Stocks back in the win column 4:27 p.m. Jan. 28, 2014 - MarketWatch
Apple sees worst day in a year; Casablanca lifts Cliffs 3:10 p.m. Jan. 28, 2014 - Ben Eisen
Pfizer beats views, even as fourth-quarter sales and earnings slide 12:28 p.m. Jan. 28, 2014 - blogs.marketwatch.com
U.S. stocks rebound on Ford, DuPont; Apple falls 9:37 a.m. Jan. 28, 2014 - Laura Mandaro
Ford shares rise 1%; Pfizer gains 2.6% 9:33 a.m. Jan. 28, 2014 - Laura Mandaro
U.S. stock futures pare gains; Apple weighs on tech 9:19 a.m. Jan. 28, 2014 - Barbara Kollmeyer
Apple's beating, TPDH and America's 'false dawn' recovery 9:17 a.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Fed policymakers gather in Washington 7:30 a.m. Jan. 28, 2014 - MarketWatch
Pfizer profit hurt by generics competition 7:23 a.m. Jan. 28, 2014 - MarketWatch.com
Pfizer shares rise after earnings beat 7:18 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer shares rise 2% premarket 7:10 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. sales of $49.2B to $51.2B 7:09 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. EPS of $2.20 to $2.30 7:08 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 EPS $0.39; Adj. EPS $0.56 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 profit falls 59% to $2.57 billion 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 sales down 2% to $13.56 billion 7:06 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Dassault Systemes Acquires Accelrys 11:17 a.m. Today - TheStreet.com
March 7th Options Now Available For Pfizer (PFE) 10:42 a.m. Today - TheStreet.com
9 New Stock Buybacks to Keep on Your Radar 5:14 a.m. Today - InvestorPlace.com
ACCL Stock – Accelrys Shares Skyrocket on Dassault Deal 3:15 a.m. Today - InvestorPlace.com
Pharma Strength Expected To Continue With Eli Lilly 8:53 p.m. Jan. 29, 2014 - Seeking Alpha
Another Strong Earnings Beat from Amgen - Analyst Blog 11:30 a.m. Jan. 29, 2014 - Zacks.com
Stock Market News for January 29, 2014 - Market News 10:06 a.m. Jan. 29, 2014 - Zacks.com
Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More 8:09 a.m. Jan. 29, 2014 - 247WallSt.com
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 29, 2014 - Zacks.com
'Mad Money' Lightning Round: Sell, Sell, Sell Windstream 6:00 a.m. Jan. 29, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products 3:01 a.m. Jan. 29, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Where Have All the Sellers Gone? 8:34 p.m. Jan. 28, 2014 - TheStreet.com
Bitter Medicine in Store for Activists 8:13 p.m. Jan. 28, 2014 - WSJ.com
Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers 7:20 p.m. Jan. 28, 2014 - WSJ.com
Pfizer's CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:04 p.m. Jan. 28, 2014 - Seeking Alpha
The 4 Stocks That Dominated the Market on Tuesday 4:02 p.m. Jan. 28, 2014 - 247WallSt.com
Pfizer coy about split/spinoff plans 2:44 p.m. Jan. 28, 2014 - Seeking Alpha
Pfizer Upbeat About Breast-Cancer Drug, Pneumonia Vaccine 2:29 p.m. Jan. 28, 2014 - WSJ.com
Pfizer Stock Floats on Financial Engineering, Not Growth 5:39 a.m. Jan. 28, 2014 - InvestorPlace.com
Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
The inscrutable gold timers 10:26 a.m. Today - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Stocks rebound, helping Dow quit loss streak; Yahoo drops after hours (Stock market live blog recap) 4:31 p.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Stocks back in the win column 4:27 p.m. Jan. 28, 2014 - MarketWatch
Apple sees worst day in a year; Casablanca lifts Cliffs 3:10 p.m. Jan. 28, 2014 - Ben Eisen
Pfizer beats views, even as fourth-quarter sales and earnings slide 12:28 p.m. Jan. 28, 2014 - blogs.marketwatch.com
U.S. stocks rebound on Ford, DuPont; Apple falls 9:37 a.m. Jan. 28, 2014 - Laura Mandaro
Ford shares rise 1%; Pfizer gains 2.6% 9:33 a.m. Jan. 28, 2014 - Laura Mandaro
U.S. stock futures pare gains; Apple weighs on tech 9:19 a.m. Jan. 28, 2014 - Barbara Kollmeyer
Apple's beating, TPDH and America's 'false dawn' recovery 9:17 a.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Fed policymakers gather in Washington 7:30 a.m. Jan. 28, 2014 - MarketWatch
Pfizer profit hurt by generics competition 7:23 a.m. Jan. 28, 2014 - MarketWatch.com
Pfizer shares rise after earnings beat 7:18 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer shares rise 2% premarket 7:10 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. sales of $49.2B to $51.2B 7:09 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. EPS of $2.20 to $2.30 7:08 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 EPS $0.39; Adj. EPS $0.56 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 profit falls 59% to $2.57 billion 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 sales down 2% to $13.56 billion 7:06 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Dassault Systemes Acquires Accelrys 11:17 a.m. Today - TheStreet.com
March 7th Options Now Available For Pfizer (PFE) 10:42 a.m. Today - TheStreet.com
9 New Stock Buybacks to Keep on Your Radar 5:14 a.m. Today - InvestorPlace.com
ACCL Stock – Accelrys Shares Skyrocket on Dassault Deal 3:15 a.m. Today - InvestorPlace.com
Pharma Strength Expected To Continue With Eli Lilly 8:53 p.m. Jan. 29, 2014 - Seeking Alpha
Another Strong Earnings Beat from Amgen - Analyst Blog 11:30 a.m. Jan. 29, 2014 - Zacks.com
Stock Market News for January 29, 2014 - Market News 10:06 a.m. Jan. 29, 2014 - Zacks.com
Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More 8:09 a.m. Jan. 29, 2014 - 247WallSt.com
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 29, 2014 - Zacks.com
'Mad Money' Lightning Round: Sell, Sell, Sell Windstream 6:00 a.m. Jan. 29, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products 3:01 a.m. Jan. 29, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Where Have All the Sellers Gone? 8:34 p.m. Jan. 28, 2014 - TheStreet.com
Bitter Medicine in Store for Activists 8:13 p.m. Jan. 28, 2014 - WSJ.com
Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers 7:20 p.m. Jan. 28, 2014 - WSJ.com
Pfizer's CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:04 p.m. Jan. 28, 2014 - Seeking Alpha
The 4 Stocks That Dominated the Market on Tuesday 4:02 p.m. Jan. 28, 2014 - 247WallSt.com
Pfizer coy about split/spinoff plans 2:44 p.m. Jan. 28, 2014 - Seeking Alpha
Pfizer Upbeat About Breast-Cancer Drug, Pneumonia Vaccine 2:29 p.m. Jan. 28, 2014 - WSJ.com
Pfizer Stock Floats on Financial Engineering, Not Growth 5:39 a.m. Jan. 28, 2014 - InvestorPlace.com
Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
(0)
(0)